FGA isoform as an indicator of targeted therapy for EGFR mutated lung adenocarcinoma

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Dacomitinib versus gefitinib as first-line treatment for patients with EGFR -mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial

(2017) Yi-Long Wu et al.   LANCET ONCOLOGY

Morbidity in combined-procedure associating abdominoplasty and breast surgery: A systematic review

(2016) A. Michot et al.   Annales de Chirurgie Plastique Esthetique

FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer

(2016) D. Kazandjian et al.   CLINICAL CANCER RESEARCH

Osimertinib: First Global Approval

(2016) Sarah L. Greig   DRUGS

Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach

(2016) Chao-Jun Hu et al.   MOLECULAR & CELLULAR PROTEOMICS

Identification of Serum Biomarkers for Gastric Cancer Diagnosis Using a Human Proteome Microarray

(2015) Lina Yang et al.   MOLECULAR & CELLULAR PROTEOMICS

Combined fibrinogen concentration and neutrophil-lymphocyte ratio as a prognostic marker of gastric cancer

(2015) TAKAAKI ARIGAMI et al.   Oncology Letters

Metformin Sensitizes EGFR-TKI-Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal

(2014) L. Li et al.   CLINICAL CANCER RESEARCH

U.S. Food and Drug Administration Approval Summary: Erlotinib for the First-Line Treatment of Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 (L858R) Substitution Mutations

(2014) Sean Khozin et al.   ONCOLOGIST

Prognostic significance of preoperative fibrinogen in patients with colon cancer

(2014) Zhen-Qiang Sun   WORLD JOURNAL OF GASTROENTEROLOGY

Mutation incidence and coincidence in non small-cell lung cancer: meta-analyses by ethnicity and histology (mutMap)

(2013) S. Dearden et al.   ANNALS OF ONCOLOGY

ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China

(2013) Liming Sheng et al.   INTERNATIONAL JOURNAL OF CANCER

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations

(2013) Lecia V. Sequist et al.   JOURNAL OF CLINICAL ONCOLOGY

Elevated Plasma Fibrinogen Levels Are Associated with a Poor Prognosis in Patients with Hepatocellular Carcinoma

(2013) Akiyoshi Kinoshita et al.   ONCOLOGY

Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays

(2013) Christoph Schröder et al.   Proteomics Clinical Applications

Development of transcriptomic biomarker signature in human saliva to detect lung cancer

(2012) Lei Zhang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

(2012) K. Ohashi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

HER2 Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in EGFR -Mutant Lung Cancers That Lack the Second-Site EGFR T790M Mutation

(2012) Ken Takezawa et al.   Cancer Discovery

Proteomic Analysis of Human Saliva From Lung Cancer Patients Using Two-Dimensional Difference Gel Electrophoresis and Mass Spectrometry

(2011) Hua Xiao et al.   MOLECULAR & CELLULAR PROTEOMICS

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

(2009) David Jackman et al.   JOURNAL OF CLINICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Agonist muscle activity and antagonist muscle co-activity levels during standardized isotonic and isokinetic knee extensions

(2008) Anthony Remaud et al.   JOURNAL OF ELECTROMYOGRAPHY AND KINESIOLOGY

Mining the plasma proteome for cancer biomarkers

(2008) Samir M. Hanash et al.   NATURE